Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
De lange en onzekere weg naar SARS-CoV-2-vaccins
aug 2020 | Vaccinatie, Virale infecties